Progress in malaria chemotherapy. 1. Repository antimalarial drugs.
D000166:Acridines / Q000627:therapeutic use; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000145:classification / Q000378:metabolism / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003622:Dapsone / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D006146:Guanidines / Q000627:therapeutic use; D007267:Injections; D000432:Methanol / Q000627:therapeutic use; D051379:Mice; D010961:Plasmodium / Q000187:drug effects; D010963:Plasmodium falciparum / Q000187:drug effects; D010965:Plasmodium malariae / Q000187:drug effects; D010966:Plasmodium vivax / Q000187:drug effects; D011739:Pyrimethamine / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
D000166:Acridines; D000962:Antimalarials; D003692:Delayed-Action Preparations; D006146:Guanidines; D011799:Quinazolines; D011804:Quinolines; D013449:Sulfonamides; D013450:Sulfones; D003622:Dapsone; D000432:Methanol; D011739:Pyrimethamine